ClinicalTrials.Veeva

Menu
H

Hospital Clinico Universitario de Valencia | Nephrology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Lenalidomide
Gemcitabine
Nivolumab
Paclitaxel
RPC1063
Carboplatin
Apraglutide
Nab-paclitaxel
Atezolizumab
IMC-F106C

Parent organization

This site is a part of Hospital Clinico Universitario de Valencia

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 6 total trials

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

This is a phase 3, randomized, controlled study of brenetafusp (IMC-F106C) plus nivolumab compared to standard nivolumab regimens in HLA-A\*02:01-pos...

Enrolling
Advanced Melanoma
Drug: Nivolumab + Relatlimab
Drug: Nivolumab

Trial sponsors

Celgene logo
BioNTech logo
Immunocore logo
Roche logo
V

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems